Novavax boosts 2026 revenue forecast as licensing deals pay off
Nov 5 (Reuters) - Vaccine maker Novavax raised its annual revenue forecast above Wall Street expectations on Thursday, banking on payments related to its li...
Thursday, November 5, 2026
Search covers the most recently published. For the full archive, browsethe topics.
1 result for"equalisation payment"
Nov 5 (Reuters) - Vaccine maker Novavax raised its annual revenue forecast above Wall Street expectations on Thursday, banking on payments related to its li...